Effect of aripiprazole 2 to 15 mg/d on health-related quality of life in the treatment of irritability associated with autistic disorder in children: a post hoc analysis of two controlled trials.

Varni, James W; Handen, Benjamin L; Corey-Lisle, Patricia K; Guo, Zhenchao; Manos, George; Ammerman, Diane K; Marcus, Ronald N; Owen, Randall; McQuade, Robert D; Carson, William H; Mathew, Suja; Mankoski, Raymond

Varni, James W; Handen, Benjamin L; Corey-Lisle, Patricia K; Guo, Zhenchao; Manos, George; Ammerman, Diane K; Marcus, Ronald N; Owen, Randall; McQuade, Robert D; Carson, William H; Mathew, Suja; Mankoski, Raymond.

Affiliation

Varni JW; Department of Pediatrics, College of Medicine, Texas A&M University, College Station, Texas.

Clin Ther ; 34(4): 980-92, 2012 Apr.

Article in En | MEDLINE | ID: mdl-22444782

Subject(s)

Antipsychotic Agents/therapeutic use; Autistic Disorder/drug therapy; Irritable Mood/drug effects; Piperazines/therapeutic use; Quality of Life; Quinolones/therapeutic use; Adolescent; Antipsychotic Agents/administration & dosage; Aripiprazole; Child; Dose-Response Relationship, Drug; Humans; Piperazines/administration & dosage; Quinolones/administration & dosage; Randomized Controlled Trials as Topic

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperazines / Quality of Life / Autistic Disorder / Antipsychotic Agents / Irritable Mood / Quinolones Type of study: Clinical_trials / Risk_factors_studies Aspects: Patient_preference Limits: Adolescent / Child / Humans Language: En Journal: Clin Ther Year: 2012 Document type: Article Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google